UNIVERSITY OF PENNSYLVANIA
ACCELERATE: An Efficient and Innovative Natural History Study Addressing Unmet Needs in Castleman Disease
ACCELERATE: An Efficient and Innovative Natural History Study Addressing Unmet Needs in Castleman Disease is a funding opportunity from UNIVERSITY OF PENNSYLVANIA, up to 397605, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
Project Summary/Abstract: Castleman disease (CD) describes a group of rare and poorly understood hematologic disorders that share characteristic histopathologic alterations, lymphadenopathy, and systemic inflammation but vary in etiology, symptomatology, treatments, and outcomes. Approximately 2,000 individuals of all…